Atlas Trials

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

Clinical trial NCT06299852 · UNKNOWN

Trial details

NCT number
NCT06299852
Sponsor
N.N. Petrov National Medical Research Center of Oncology
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
HER2-positive Metastatic Breast CancerOligometastatic Disease
Start date
2022-07-01
Primary completion
2025-09-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.